Neurology

The Pharmacy Times® Neurology resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

What can we help you find?
[[thumbnail_alt_text]]
A study by the American Academy of Neurology suggests that taking a low-dose aspirin once per day does not reduce the risk of thinking and memory problems caused by mild cognitive impairment or possible Alzheimer disease.
[[thumbnail_alt_text]]
Ozanimod demonstrated acceptable safety and tolerability in the phase 3 SUNBEAM and RADIANCE part B trials.
[[thumbnail_alt_text]]
The study focused on whether moderate alcohol intake is related to reductions in amyloid-beta deposition or is protective via amyloid-independent mechanisms in the living human brain since little information was available.
[[thumbnail_alt_text]]
The spray is the first nasal spray treatment for seizure cluster rescue.
[[thumbnail_alt_text]]
Few drugs are available to address cognitive decline, but dietary changes, mental and physical activity, and social engagement can all help.
[[thumbnail_alt_text]]
Few drugs are available to address cognitive decline, but dietary changes, mental and physical activity, and social engagement can all help.
[[thumbnail_alt_text]]
Higher dietary intake of flavonols may be associated with a lower risk of developing Alzheimer dementia.
[[thumbnail_alt_text]]
Many options are available, but no single one is effective for all symptoms of this disorder.
[[thumbnail_alt_text]]
The medication works by blocking CGRP receptors, treating a root cause of migraine.
[[thumbnail_alt_text]]
Why is KM taking such a high dose of prednisone?
[[thumbnail_alt_text]]
Study findings provide further basis for dietary interventions as future treatments for disorders such as multiple sclerosis.
[[thumbnail_alt_text]]
The release of generic versions of brand name drugs for patients with multiple sclerosis had little overall effect on the price increase.